Literature DB >> 21753719

Expressional and mutational analysis of PHLDA3 gene in common human cancers.

Nam Jin Yoo, Yoo Ri Kim, Sug Hyung Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21753719     DOI： 10.1097/PAT.0b013e3283489036

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  3 in total

1.  PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors.

Authors:  Rieko Ohki; Kozue Saito; Yu Chen; Tatsuya Kawase; Nobuyoshi Hiraoka; Raira Saigawa; Maiko Minegishi; Yukie Aita; Goichi Yanai; Hiroko Shimizu; Shinichi Yachida; Naoaki Sakata; Ryuichiro Doi; Tomoo Kosuge; Kazuaki Shimada; Benjamin Tycko; Toshihiko Tsukada; Yae Kanai; Shoichiro Sumi; Hideo Namiki; Yoichi Taya; Tatsuhiro Shibata; Hitoshi Nakagama
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

2.  A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET).

Authors:  Antonio Viúdez; Filipe L F Carvalho; Zahra Maleki; Marianna Zahurak; Daniel Laheru; Alejandro Stark; Nilofer S Azad; Christopher L Wolfgang; Stephen Baylin; James G Herman; Ana De Jesus-Acosta
Journal:  Oncotarget       Date:  2016-05-03

3.  Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.

Authors:  Jia Liu; Xiaoxiong Liu; Xuejun Hui; Lin Cai; Xuebo Li; Yang Yang; Shangzhi Shu; Fan Wang; Hao Xia; Shuyan Li
Journal:  J Am Heart Assoc       Date:  2019-08-20       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.